Feb 24, 2021 / 10:30PM GMT
Operator
Thank you for standing by, and welcome to the Nova Eye Medical first half results presentation. (Operator Instructions)
I would now like to hand the conference over to Mr. Tom Spurling, Director. Please go ahead.
Thomas H. Spurling - Nova Eye Medical Limited - Consultant & Director
Good morning, everyone. Thanks for taking the time to listen to the story of our first half results. I have with me today Victor Previn in the room here in Kent Town in Adelaide in our office (inaudible) as well.
So we have the deck. If we could just -- we have the disclaimer, and then we fall through to our first slide on Page 3, discussion of our business. As all of you are aware, following the sale of business -- the Laser and Ultrasound business, our Nova Eye -- renamed Nova Eye business comprises 2 segments rather than 3, a glaucoma surgical devices business and a business in laser therapy for chronic age-related retinal conditions.
First on the glaucoma surgical devices segment. Glaucoma is the leading cause of blindness in the developed world.
Half Year 2021 Nova Eye Medical Ltd Earnings Call Transcript
Feb 25, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers